Pan-cancer investigation of psoriasis-related BUB1B gene: genetical alteration and oncogenic immunology

Sci Rep. 2023 Apr 13;13(1):6058. doi: 10.1038/s41598-023-33174-3.

Abstract

Unknown factors contribute to psoriasis' hyperproliferative, chronic, inflammatory, and arthritic features. Psoriasis patients have been linked to an increased risk of cancer, though the underlying genetics remain unknown. Since our prior research indicated that BUB1B contributes to the development of psoriasis, we designed and carried out this investigation using bioinformatics analysis. Using the TCGA database, we investigated the oncogenic function of BUB1B in 33 tumor types. To sum up, our work sheds light on BUB1B's function in pan-cancer from various perspectives, including its pertinent signaling pathways, mutation locations, and connection to immune cell infiltration. BUB1B was shown to have a non-negligible role in pan-cancer, which is connected to immunology, cancer stemness, and genetic alterations in a variety of cancer types. BUB1B is highly expressed in a variety of cancers and may serve as a prognostic marker. This study is anticipated to offer molecular details on the elevated cancer risk that psoriasis sufferers experience.

MeSH terms

  • Cell Cycle Proteins
  • Computational Biology
  • Databases, Factual
  • Humans
  • Inflammation
  • Neoplasms* / genetics
  • Protein Serine-Threonine Kinases / genetics
  • Psoriasis* / genetics

Substances

  • BUB1B protein, human
  • Protein Serine-Threonine Kinases
  • Cell Cycle Proteins